GROUP SITES OUR RESPONSE TO COVID-19 Menu INVESTOR INFORMATION Investor Overview INVESTOR OVERVIEW We are a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, positioning us well to maximise the value we create for our business and our diverse stakeholders. We supply medicines to more than 150 countries and have 69 established business offices in more than 50 countries. We focus on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. FAST FACTS OUR INVESTMENT CASE Our vision inspires our actions To deliver value to our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines globally. Global footprint with weighting towards emerging markets Strategically relevant manufacturing capital Responsible corporate citizen and trusted partner Diverse product portfolio with strong brand equity Committed management team, strongly aligned with shareholders’ interests Commercial and sales employees: 2 088 in emerging countries 304 in developed countries Medicines supplied to more than 130 emerging and over 25 developed countries GROSS PROFIT BY BUSINESS SEGMENT (%) SENS ANNOUNCEMENTS SHARE PRICE CENTRE VIEW SHARE PRICE INFORMATION FOR ASPEN HOLDINGS. SHARE CODE APN ISIN: ZAE 000066692 JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual. PRESENTATIONS Annual Results Presentation for the year ended 30 June 2021 PDF 9.7Mb READ MORE READ MORE READ MORE CAPITAL DISTRIBUTIONS All capital distributions to date READ MORE SHAREHOLDER STATISTICS Analysis of shareholders at 30 June 2019 READ MORE CORPORATE INFORMATION All corporate information and contact details READ MORE REGISTER FOR ALERTS Register via Vault for alerts of SENS announcements, reports and event invitations. CONTACT DETAILS Investor Relations +27 31 580 8600 InvestorRelations@aspenpharma.com WEBCASTS Click to view the webcast recording of our Financial Results for the year ended 30 June 2021 Click here to view our Investor Day webcast of 11 December 2020 INVESTOR CALENDAR 09 December 2021 Annual General Meeting READ MORE © 2021 Aspen Holdings Disclaimer Privacy Statement Aspen PAIA & POPI Manual Standard Terms of purchase of goods or services (STC) Contact details Designed & Produced by Bastion Graphics Cookie consent This website uses cookies that help the website to function and also to track how you interact with our website. But for us to provide the best user experience, enable the specific cookies from Settings, and click on Accept. PreferencesReject AllAccept All